These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 173499)

  • 21. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M; Ikegami N; Chatani M; Yoshino K; Sato T
    Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M; Prasad U
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups.
    Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Lee HH; Kuo SL
    J Med Virol; 1987 Sep; 23(1):11-21. PubMed ID: 2824675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency.
    Chen CJ; Liang KY; Chang YS; Wang YF; Hsieh T; Hsu MM; Chen JY; Liu MY
    Anticancer Res; 1990; 10(2B):547-53. PubMed ID: 2161639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
    J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R; Gurtsevich V; Le Riverend E
    Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH; Soo MY; Gan YY; Fones-Tan A; Sim PS; Kaur A; Chew CT
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP; Hilgers R; Skvaril F
    Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
    Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
    HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasopharyngeal carcinoma and Epstein-Barr virus--associated serologic markers.
    Tam JS; Murray HG
    Ear Nose Throat J; 1990 Apr; 69(4):261-7. PubMed ID: 2161732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasopharyngeal carcinoma and Epstein-Barr virus. III. The detection of anti-nuclear antibodies.
    Lynn TC; Hsu MM; Hsieh T; Tu SM; Hamajima K
    Jpn J Exp Med; 1976 Oct; 46(5):289-95. PubMed ID: 189106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
    Kumar S; Wairagkar NS; Mahanta J
    Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.